D. Greenberg

发表

A. Chit, M. Decker, C. Robertson, 2016, Expert review of vaccines.

Feasibility of influenza immunization for inner-city children aged 6 to 23 months.

M. Nowalk, S. Weinberg, A. Hoberman, 2004, American journal of preventive medicine.

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D) in infants and children.

M. Decker, C. Robertson, D. Greenberg, 2018, Vaccine.

Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine.

M. Decker, C. Robertson, D. Greenberg, 2017, Vaccine.

Update on the development and use of viral and bacterial vaccines for the prevention of acute otitis media.

D. Greenberg, 2001, Allergy and asthma proceedings.

Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014.

J. P. Davis, J. Eickhoff, M. Decker, 2020, Vaccine.

Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Impl

V. Waters, S. Halperin, J. Bettinger, 2009, The Pediatric infectious disease journal.

A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine

S. Black, D. Greenberg, 2005, Expert review of vaccines.

Effect of Previous-Year Vaccination on the Efficacy, Immunogenicity, and Safety of High-Dose Inactivated Influenza Vaccine in Older Adults

C. Robertson, C. Diazgranados, D. Greenberg, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.

C. Diazgranados, D. Greenberg, G. Gorse, 2014, Vaccine.

Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age

M. Decker, C. Robertson, D. Greenberg, 2014, The Pediatric infectious disease journal.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.

M. Decker, C. Robertson, D. Greenberg, 2013, Vaccine.

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.

A. Falsey, D. Greenberg, G. Gorse, 2013, Vaccine.

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

D. Bernstein, W. Keitel, K. Edwards, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.

A. Chit, D. Greenberg, Thomas Shin, 2020, Vaccine.

Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis

A. Chit, D. Greenberg, Thomas Shin, 2018, Expert review of vaccines.

Safety and Immunogenicity of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administered to Children 10 or 11 Years of Age

M. Decker, D. Greenberg, David R. Johnson, 2014, Clinical and Vaccine Immunology.

Treatment of children with congenital cytomegalovirus infection with ganciclovir

D. Greenberg, E. Wald, M. Michaels, 2003, The Pediatric infectious disease journal.

Characterization, Distribution, and Expression of Novel Genes among Eight Clinical Isolates of Streptococcuspneumoniae

G. Ehrlich, D. Greenberg, F. Hu, 2006, Infection and Immunity.

Pneumococcal Resistance and Serotype 19A in Pittsburgh-Area Children With Acute Otitis Media Before and After Introduction of 7-Valent Pneumococcal Polysaccharide Vaccine

H. Rockette, A. Hoberman, N. Shaikh, 2011, Clinical pediatrics.

Eradication of Haemophilus influenzae type b disease in southern California. Kaiser-UCLA Vaccine Study Group.

L. Mascola, D. Greenberg, E. Eriksen, 1994, Archives of pediatrics & adolescent medicine.

Safety and immunogenicity of a quadrivalent influenza vaccine in adults 65 y of age and older

M. Decker, C. Robertson, D. Greenberg, 2017, Human vaccines & immunotherapeutics.

Interchangeability of 2 diphtheria-tetanus-acellular pertussis vaccines in infancy.

M. Pichichero, K. Reisinger, D. Greenberg, 2002, Pediatrics.

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial.

D. Greenberg, C. Vadheim, J. Ward, 1996, The Journal of infectious diseases.

Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

D. Greenberg, J. Ward, S. Partridge, 2000, The Pediatric infectious disease journal.

Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines.

D. Greenberg, J. Lieberman, S. M. Marcy, 1995, The Journal of pediatrics.

Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy

M. Decker, D. Greenberg, David R. Johnson, 2013, The Pediatric infectious disease journal.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants.

D. Greenberg, J. Ward, P. Mendelman, 2003, Vaccine.

Risk factors for invasive Haemophilus influenzae type b in Los Angeles County children 18-60 months of age.

D. Greenberg, S. Waterman, C. Vadheim, 1992, American journal of epidemiology.

Highly differentiated human airway epithelial cells: a model to study host cell–parasite interactions in pertussis

F. Mooi, J. Gaddy, M. Decker, 2016, Infectious diseases.

Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.

S. Yeh, D. Greenberg, J. Ward, 2003, Vaccine.

Current issues in adolescent immunization.

P. van Damme, D. Greenberg, L. Hessel, 2008, Vaccine.

Summary: Health and Economic Burden of Pertussis

J. Caro, D. Greenberg, 2005, The Pediatric infectious disease journal.

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age

C. Robertson, M. Mercer, D. Greenberg, 2018, The Pediatric infectious disease journal.

CASE REPORT: Clostridium difficile Colitis in Children with Cystic Fibrosis

D. Greenberg, D. Orenstein, S. Khan, 2004, Digestive Diseases and Sciences.

Smallpox vaccination recommendations for contacts of pediatric cancer patients

K. Edwards, B. Schwartz, D. Greenberg, 2004, Pediatric blood & cancer.

Haemophilus Disease in Alaskan and Canadian Children

V. Waters, S. Halperin, J. Bettinger, 2010 .

Immunogenicity of Haemophilus influenzae type b tetanus toxoid conjugate vaccine in young infants. The Kaiser-UCLA Vaccine Study Group.

D. Greenberg, C. Vadheim, J. Ward, 1994, The Journal of infectious diseases.

Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.

D. Greenberg, S. Waterman, C. Vadheim, 1991, JAMA.

Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as Etiologic Agents of Persistent Cough in Adolescents and Adults

L. Kingsley, D. Greenberg, J. Ward, 2002, Journal of Clinical Microbiology.

Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines.

D. Greenberg, J. Lieberman, J. Ward, 1995, The Journal of pediatrics.

Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group.

D. Greenberg, C. Vadheim, J. Ward, 1993, Pediatrics.

Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses.

J. Ryan, D. Greenberg, G. Calandra, 1993, Vaccine.

Safety and Immunogenicity of the American Academy of Pediatrics–Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients

G. Mazariegos, D. Greenberg, S. Webber, 2005, Pediatrics.

Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents

D. Greenberg, 2005, The Pediatric infectious disease journal.

Vaccine prevention of acute otitis media

A. Hoberman, D. Greenberg, 2001, Current allergy and asthma reports.

Health and economic burden of pertussis

J. Caro, D. Greenberg, 2005 .

Vaccine Interchangeability

D. Greenberg, S. Feldman, 2003, Clinical pediatrics.

Persistence of bactericidal antibodies 4 years after a booster dose of quadrivalent meningococcal diphtheria toxoid conjugate vaccine (MenACWY-D).

J. Hedrick, C. Robertson, D. Greenberg, 2019, Vaccine.

Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study.

L. Mascola, D. Greenberg, E. Eriksen, 1994, The Pediatric infectious disease journal.

Clinician Satisfaction with Vaccination Visits and the Role of Multiple Injections, Results from the Covise Study (Combination Vaccines Impact on Satisfaction and Epidemiology)

D. Greenberg, R. Jacobs, A. Meyerhoff, 2004, Clinical pediatrics.

Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.

J. Hedrick, M. Pichichero, M. Decker, 2016, Vaccine.

Safety and Immunogenicity of a Pentavalent Vaccine Compared With Separate Administration of Licensed Equivalent Vaccines in US Infants and Toddlers and Persistence of Antibodies Before a Preschool Booster Dose: A Randomized, Clinical Trial

M. Pichichero, D. Greenberg, F. Noriega, 2009, Pediatrics.

Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers.

M. Decker, D. Greenberg, V. Pool, 2016, Vaccine.

Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay

P. Anderson, D. Greenberg, J. Ward, 1988, Journal of clinical microbiology.

Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age.

H. Margolis, D. Greenberg, S. M. Marcy, 1996, The Pediatric infectious disease journal.

Protective efficacy of protein A-specific antibody against bacteremic infection due to Staphylococcus aureus in an infant rat model

D. Greenberg, A. Cheung, A. Bayer, 1989, Infection and immunity.

Infection and immunity toStaphylococcus aureus andHaemophilus influenzae

D. Greenberg, H. Stutman, 1991, Clinical Reviews in Allergy.

Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

D. Greenberg, H. Stutman, 1991, Clinical reviews in allergy.

Penicillin Susceptibility of Pneumococcal Isolates Causing Acute Otitis Media in Children: Seasonal Variation

A. Hoberman, D. Kearney, D. Greenberg, 2005, The Pediatric infectious disease journal.

Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska native, and non-native American children aged <2 years.

D. Greenberg, M. Santosham, R. Reid, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Health Burden of Pertussis in Infants and Children

D. Greenberg, U. Heininger, C. W. von König, 2005, The Pediatric infectious disease journal.

Factors influencing immunogenicity and safety of two Haemophilus influenzae type b polysaccharide vaccines in children 18 and 24 months of age.

D. Greenberg, S. M. Marcy, J. Ward, 1987, The Pediatric infectious disease journal.

Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.

D. Greenberg, A. Bayer, J. Yih, 1988, Chemotherapy.

Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media.

Garth D Ehrlich, Paul Stoodley, P Ashley Wackym, 2006, JAMA.

Efficacy of high-dose versus standard-dose influenza vaccine in older adults.

John Earl, S. Gurunathan, M. Decker, 2014, The New England journal of medicine.

Parental perspectives on influenza immunization of children aged 6 to 23 months.

M. Nowalk, A. Hoberman, D. Kearney, 2005, American journal of preventive medicine.

Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies.

D. Greenberg, 1993, The Pediatric infectious disease journal.

Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study Group.

H. Margolis, D. Greenberg, S. M. Marcy, 1996, Vaccine.

Considerations for hepatitis B as part of a combination vaccine

D. Greenberg, 2001, The Pediatric infectious disease journal.

Hepatitis B today: New guidelines for the pediatrician-discussion

D. Greenberg, N. Halsey, R. Koff, 1993 .

Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits

D. Greenberg, A. Bayer, J. Ward, 1987, Infection and immunity.

Regional variation in the cost effectiveness of childhood hepatitis A immunization

S. Saab, D. Greenberg, R. Jacobs, 2003, The Pediatric infectious disease journal.

Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017

M. Cetron, M. Sotir, D. Greenberg, 2017, MMWR. Morbidity and mortality weekly report.

Fluzone® Intradermal Quadrivalent Influenza Vaccine

C. Robertson, D. Greenberg, V. Landolfi, 2016, Expert review of vaccines.

Prevention and control of influenza and dengue through vaccine development.

C. Robertson, D. Greenberg, D. Gordon, 2013, Pediatric annals.

Lack of Evidence of Borrelia Involvement in A lzheimer's D isease

K. Reisinger, E. Walter, R. Jacobson, 2000 .

Efficacy of an acellular pertussis vaccine among adolescents and adults.

Susan Partridge, D. Bernstein, W. Keitel, 2005, The New England journal of medicine.

Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis

P. S. Leventhal, D. Greenberg, S. Samson, 2019, Expert review of vaccines.

Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.

C. Robertson, C. Diazgranados, D. Greenberg, 2015, Vaccine.

Prevention of Serious Events in Adults 65 Years of Age or Older: A Comparison Between High-dose and Standard-dose Inactivated Influenza Vaccines

C. Robertson, C. Diazgranados, D. Greenberg, 2014 .

Improving Influenza Vaccination Rates of High-Risk Inner-City Children Over 2 Intervention Years

M. Nowalk, S. Weinberg, A. Hoberman, 2006, The Annals of Family Medicine.

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine

M. Decker, D. Greenberg, David R. Johnson, 2014, The Journal of infectious diseases.

Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

R. Balicer, E. Kepten, N. Dagan, 2021, Vaccine.

Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.

D. Bernstein, W. Keitel, J. Treanor, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.

A. Chit, Y. Young-Xu, D. Greenberg, 2019, Vaccine.

Prevention of Invasive Meningococcal Disease in the United States: Current State of the Art

M. Decker, C. Robertson, D. Greenberg, 2013 .

Introductory paper: High dose influenza vaccine.

A. Chit, M. Mercer, D. Greenberg, 2021, Vaccine.

Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.

C. Robertson, C. Diazgranados, D. Greenberg, 2015, Vaccine.

Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.

Ayman Chit, A. Chit, D. Greenberg, 2015, Vaccine.

Predicted Effects of a New Combination Vaccine on Childhood Immunization Coverage Rates and Vaccination Activities

D. Greenberg, A. Meyerhoff, R. Jake Jacobs, 2005 .

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial.

J. Lave, H. Rockette, A. Hoberman, 2003, JAMA.

Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six months of age

D. Greenberg, J. Ward, S. Partridge, 2002, The Pediatric infectious disease journal.

2-dose hepatitis vaccination versus 3-dose regimen.

D. Greenberg, A. Meyerhoff, 2002, Pediatrics.

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

E. Lewis, M. Decker, D. Greenberg, 2021, The Pediatric Infectious Disease Journal.

Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.

M. Decker, D. Greenberg, A. Tomovici, 2018, Vaccine.

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

D. Bernstein, M. Decker, M. Hall, 2018, Journal of the Pediatric Infectious Diseases Society.

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine

M. Decker, D. Greenberg, David R. Johnson, 2016, Human vaccines & immunotherapeutics.

Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not supported when data are stratified by age.

M. Decker, D. Greenberg, David R. Johnson, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy.

R. Karron, R. Walker, K. Reisinger, 2005, The Journal of infectious diseases.

Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants.

K. Reisinger, S. Yeh, R. Yogev, 2001, The Journal of infectious diseases.

Cryptosporidial infections after solid organ transplantation in children

D. Gerber, G. Mazariegos, J. Reyes, 2000, Pediatric transplantation.

Gastrointestinal Events in High-Dose vs Standard-Dose Influenza Vaccine Recipients

C. Robertson, C. Diazgranados, D. Greenberg, 2018, Open forum infectious diseases.

Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method.

A. Chit, Y. Young-Xu, D. Greenberg, 2019, Vaccine.

Antibody responses to protein A in patients with Staphylococcus aureus bacteremia and endocarditis

D. Greenberg, A. Bayer, J. Ward, 1990, Journal of clinical microbiology.

Safety evaluation of PRP‐D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow‐up study of 30000 children

D. Greenberg, C. Vadheim, J. Ward, 1990, The Pediatric infectious disease journal.